alpha-aminopyridine has been researched along with midazolam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Martinez-Aguirre, E; Sansano, C | 1 |
| Blume, H; Erb, KA; Hermann, R; Knoerzer, D; Lahu, G; Nassr, N; Reutter, F; Schug, B; von Richter, O; Zech, K | 1 |
| Chakraborty, A; Dhuria, SV; Elmeliegy, M; He, H; Heimbach, T; Huth, F; Ji, Y; Miller, M; Samant, TS; Schiller, H; Umehara, K | 1 |
3 trial(s) available for alpha-aminopyridine and midazolam
| Article | Year |
|---|---|
Comparison of midazolam (Ro 21-3981) and diazepam as complement of ketamine-air anesthesia in children.
Topics: 4-Aminopyridine; Aminopyridines; Anesthesia, General; Atropine; Benzodiazepines; Child; Child, Preschool; Clinical Trials as Topic; Diazepam; Female; Hemodynamics; Humans; Hypnotics and Sedatives; Infant; Ketamine; Male; Midazolam; Prospective Studies; Random Allocation; Time Factors | 1986 |
Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects.
Topics: Adult; Aminopyridines; Anti-Anxiety Agents; Benzamides; Cyclopropanes; Drug Interactions; Humans; Male; Midazolam; Phosphodiesterase Inhibitors | 2007 |
Ribociclib Drug-Drug Interactions: Clinical Evaluations and Physiologically-Based Pharmacokinetic Modeling to Guide Drug Labeling.
Topics: Administration, Oral; Aminopyridines; Animals; Antineoplastic Agents; Biotransformation; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Labeling; Healthy Volunteers; Humans; Midazolam; Models, Theoretical; Patient Safety; Purines; Rifampin; Risk Assessment; Ritonavir | 2020 |